Skip to main content
  • Saved

made a Post

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

The promise of adoptive cellular immunotherapies in hepatocellular carcinoma

Source : https://www.tandfonline.com/doi/full/10.1080/2162402X.2019.1673129

ABSTRACT ABSTRACT Hepatocellular Carcinoma (HCC) is one of the leading causes of cancer-related mortality worldwide. Current systemic therapies result only in modest benefits and new therapeutic options are critically needed. Some patients show promising clinical responses to immune checkpoint inhibitors, however, additional immunotherapeutic approaches, such as adoptive cell therapies (ACT), need to be developed.

Sign In or Register Today to Access This Content